Caerin 1.5

General Information


DRACP ID  DRACP04681

Peptide Name   Caerin 1.5

Sequence  GLLSVLGSVVKHVIPHVVPVIAEHL

Sequence Length  25

UniProt ID  P56230 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Amidation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C123H206N32O30

Absent amino acids  CDFMNQRTWY

Common amino acids  V

Mass  304147

Pl  7.81

Basic residues  4

Acidic residues  1

Hydrophobic residues  14

Net charge  3

Boman Index  2835

Hydrophobicity  131.2

Aliphatic Index  178.8

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 9516047

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 15203252

Title  Not available

Doi Not available

Year  Not available

Literature 3

Pubmed ID 14744137

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.